Prot#RIN-PH-403: A Postmarketing Observational Study to Assess Respiratory Tract Adverse Events in Pulmonary Arterial Hypertension Patients Treated with Tyvaso (Treprostinil) Inhalation Solution

Project: Research project

Project Details

StatusFinished
Effective start/end date9/29/112/28/15

Funding

  • United Therapeutics Corporation (RIN-PH-403)